Works matching IS 03618609 AND DT 2020 AND VI 95 AND IP 2

Results: 21
    1

    Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m<sup>2</sup> in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m<sup>2</sup>.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 2, p. E51, doi. 10.1002/ajh.25695
    By:
    • Barley, Kevin;
    • Sanchez, Larysa;
    • Cho, Hearn J.;
    • Parekh, Samir;
    • Madduri, Deepu;
    • Richter, Joshua;
    • Isola, Luis;
    • Goldstein, Talia;
    • Dhadwal, Amishi;
    • Zarychta, Katarzyna;
    • Sanchez, Gillian Morgan;
    • Catamero, Donna;
    • Verina, Daniel;
    • Florendo, Erika;
    • Yum, Moon‐hee;
    • La, Lisa;
    • Gullie, Jude;
    • Chan, Elaine;
    • Jagannath, Sundar;
    • Chari, Ajai
    Publication type:
    Article
    2
    3
    4
    5
    6

    Cerebral fat embolism in sickle cell disease.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 2, p. E41, doi. 10.1002/ajh.25686
    By:
    • Gendreau, Segolene;
    • Scholer, Margaux;
    • Cecchini, Jérôme;
    • Habibi, Anoosha;
    • Razazi, Keyvan;
    • De Prost, Nicolas;
    • Carteaux, Guillaume;
    • Bartolucci, Pablo;
    • Gendre, Thierry;
    • Brugieres, Pierre;
    • Hodel, Jérôme;
    • Mekontso Dessap, Armand
    Publication type:
    Article
    7
    8
    9
    10

    Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 2, p. 178, doi. 10.1002/ajh.25680
    By:
    • Newland, Adrian C.;
    • Sánchez‐González, Blanca;
    • Rejtő, László;
    • Egyed, Miklos;
    • Romanyuk, Nataliya;
    • Godar, Marie;
    • Verschueren, Katrien;
    • Gandini, Domenica;
    • Ulrichts, Peter;
    • Beauchamp, Jon;
    • Dreier, Torsten;
    • Ward, E. Sally;
    • Michel, Marc;
    • Liebman, Howard A.;
    • Haard, Hans;
    • Leupin, Nicolas;
    • Kuter, David J.
    Publication type:
    Article
    11

    Impact of natural neuromedin‐B receptor variants on iron metabolism.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 2, p. 167, doi. 10.1002/ajh.25679
    By:
    • Rametta, Raffaela;
    • Dongiovanni, Paola;
    • Baselli, Guido A.;
    • Pelusi, Serena;
    • Meroni, Marica;
    • Fracanzani, Anna L.;
    • Busti, Fabiana;
    • Castagna, Annalisa;
    • Scarlini, Stefania;
    • Corradini, Elena;
    • Pietrangelo, Antonello;
    • Girelli, Domenico;
    • Fargion, Silvia;
    • Valenti, Luca
    Publication type:
    Article
    12
    13

    Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 2, p. 156, doi. 10.1002/ajh.25677
    By:
    • Sant'Antonio, Emanuela;
    • Guglielmelli, Paola;
    • Pieri, Lisa;
    • Primignani, Massimo;
    • Randi, Maria Luigia;
    • Santarossa, Claudia;
    • Rumi, Elisa;
    • Cervantes, Francisco;
    • Delaini, Federica;
    • Carobbio, Alessandra;
    • Betti, Silvia;
    • Rossi, Elena;
    • Lavi, Noa;
    • Harrison, Claire N.;
    • Curto‐Garcia, Natalia;
    • Gisslinger, Heinz;
    • Gisslinger, Bettina;
    • Specchia, Giorgina;
    • Ricco, Alessandra;
    • Vianelli, Nicola
    Publication type:
    Article
    14
    15

    Cutaneous blastic plasmacytoid dendritic cell neoplasm arising in the context of TET2 and ZRSR2 mutated clonal cytopenias of unknown significance, secondary to somatic copy number losses involving CDK2NA/2NB and MTAP.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 2, p. E31, doi. 10.1002/ajh.25675
    By:
    • Li, Marissa;
    • Shah, Mithun;
    • Binder, Moritz;
    • Lasho, Terra;
    • Carr, Ryan;
    • Mangaonkar, Abhishek;
    • Gangat, Naseema;
    • Coltro, Giacomo;
    • Tefferi, Ayalew;
    • Dao, Linda;
    • Peters, Margot;
    • Chiu, April;
    • Patnaik, Mrinal M.
    Publication type:
    Article
    16

    Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 2, p. 151, doi. 10.1002/ajh.25674
    By:
    • Foss, Francine M.;
    • Horwitz, Steven M.;
    • Civallero, Monica;
    • Bellei, Monica;
    • Marcheselli, Luigi;
    • Kim, Won Seog;
    • Cabrera, Maria E.;
    • Dlouhy, Ivan;
    • Nagler, Arnon;
    • Advani, Ranjana H.;
    • Pesce, Emanuela A.;
    • Ko, Young‐Hyeh;
    • Montoto, Silvia;
    • Chiattone, Carlos;
    • Moskowitz, Alison;
    • Spina, Michele;
    • Cesaretti, Marina;
    • Biasoli, Irene;
    • Federico, Massimo
    Publication type:
    Article
    17
    18
    19

    The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia‐negative B‐cell acute lymphoblastic leukemia is a strong predictor for survival.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 2, p. 144, doi. 10.1002/ajh.25671
    By:
    • Yilmaz, Musa;
    • Kantarjian, Hagop;
    • Wang, Xuemei;
    • Khoury, Joseph D.;
    • Ravandi, Farhad;
    • Jorgensen, Jeffrey;
    • Short, Nicholas J.;
    • Loghavi, Sanam;
    • Cortes, Jorge;
    • Garcia‐Manero, Guillermo;
    • Kadia, Tapan;
    • Sasaki, Koji;
    • Konopleva, Marina;
    • Takahashi, Koichi;
    • Wierda, William;
    • Jain, Nitin;
    • Verstovsek, Srdan;
    • Estrov, Zeev;
    • Bose, Prithviraj;
    • Pierce, Sherry
    Publication type:
    Article
    20
    21